Skip to content

Diffusion Tensor Imaging of Myelopathy

Role of Diffusion Tensor Imaging in Evaluation of Myelopathy

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03665935
Acronym
DTI
Enrollment
70
Registered
2018-09-11
Start date
2018-09-30
Completion date
2019-12-31
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myelopathy

Brief summary

Myelopathy describes any neurologic deficit related to the spinal cord. Myelopathy is caused by various pathological states of the human spinal cord, including tumors, inflammatory lesions, spinal cord compression and degenerative myelopathy. Clinically, the diagnosis of myelopathy depends on localization of the neurologic finding to the spinal cord, rather than the brain or peripheral nervous system and then to a particular segment of the spinal cord. Magnetic resonance imaging (MRI) plays an essential role in the diagnosis and follow-up of the lesions of the spinal cord using conventional MRI T1- and T2-weighted sequences. Sometimes a studied spinal cord may appear normal on conventional MRI even though patients have symptoms of myelopathy causing a discrepancy between MRI findings and clinical findings. Diffusion tensor imaging (DTI) is an advanced non-invasive MR imaging technique which assesses the microstructural integrity of nerve fiber tracts.

Detailed description

A number of 70 patient with myelopathy included within the study. DTI is used primarily for assessing white matter of the brain and spinal cord. DTI can depict alterations to the white matter tract and quantify these changes. Disturbances of diffusion (restriction or increase) may be assessed quantitatively by measurements of apparent diffusion coefficient (ADC). The apparent diffusion coefficient (ADC), is used to measure diffusive strength. Diffusion anisotropy can be assessed quantitatively by using the fractional anisotropy (FA) parameter, which may be also visualized on fractional anisotropy maps. FA is considered as a marker of white matter integrity. Image acquisition will be conducted on a 1.5-Tesla MR scanner. The imaging will be done throughout the following sequences: 1. Conventional MRI sequences: sagittal T1W, sagittal and axial T2W sequences. 2. DTI sequence: Single-shot spin-echo echo-planar imaging (EPI) and parallel imaging techniques to achieve motion-free and higher signal-to-noise ratio (SNR) DTI. Post processing: The diffusion-tensor imaging data is transferred to an offline workstation utilizing software used for reconstruction of the Diffusion Tensor imaging (DTI) with regions of interest were defined and measured on the ADC and fractional anisotropy (FA) maps. diffusion tensor tractogram will be constructed on the acquired data source.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Clinical symptoms of myelopathy

Exclusion criteria

* Previous spine surgery * Spine radiation therapy * Cerebral palsy * Contraindication to MR imaging.

Design outcomes

Primary

MeasureTime frameDescription
To determine the usefulness of diffusion tensor imaging (DTI) and fiber tracking in evaluation of myelopathy.one yearassessing white matter tract affection in various disease and damage involving the spinal cord using the DTI indices, quantitatively using ADC and FA measurement and qualitatively using tractogram to assess spinal cord lesions and compare the results to conventional MRI sequences

Contacts

Primary ContactAbd El-Karem Hasan, professor
abdelkarem_5555@yahoo.com01224652032
Backup ContactMohamed Zidan, A.professor
mzidan74@yahoo.com01001121365

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026